Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin

Yaoxue Xuebao

Volumn 41, Issue 12, 2006, Pages 1146-1151

  Shi, Yi Kang ^a   Wu, Shu Ying ^a   Huang, Yun Hong ^a   Zhen, Yong Su ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Lidamycin; mdr1 gene; Multiple drug resistance; P glycoprotein

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC C 1027; ANTINEOPLASTIC ANTIBIOTIC; ENEDIYNE; GLYCOPROTEIN P;

ARTICLE; DRUG RESISTANCE; GENE; GENETIC TRANSFECTION; GENETICS; HUMAN; MULTIDRUG RESISTANCE; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

AMINOGLYCOSIDES; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENEDIYNES; GENES, MDR; HUMANS; NEOPLASMS; P-GLYCOPROTEIN; TRANSFECTION;

EID: 33847230885     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tsuruo T. Molecular cancer therapeutics: recent progress and targets in drug resistance [J]. Intern Med, 2003,42:237-243.
2. Zhen YS, Min XY, Yu B, et al. A new macromolecular antitumor antibiotic, C-1027 III [J]. J Antibiot, 1989,42:1294-1298.
3. Jiang B, Li DD, Zhen YS. Induction of apoptosis by enediyne antitumor antibiotic C-1027 in HL-60 human promyelocytic leukemia cells [J]. Biochem Biophys Res Commun, 1995,208:238-244.
4. He QY, Liang YY, Wang DS, et al. Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells [J]. Int J Oncol, 2002,20:261-266.
5. Baker EK, Johnstone RW, Zalcberg JR, et al. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs [J]. Oncogene, 2005,24:8061-8075.
6. Chen KG, Wang YC, Schaner ME, et al. Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line [J]. Cancer Res, 2005,65:9388-9397.
7. Yusuf RZ, Duan Z, Lamendola DE, et al. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation [J]. Curr Cancer Drug Targets, 2003,3:1-19.
8. Kamazawa S, Kigawa J, Kanamori Y, et al. Multidrug resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer [J]. Gynecol Oncol, 2002,86:171-176.
9. Jang SH, Wientjes MG, Au JL. Kinetics of P-glycoprotein-mediated efflux of paclitaxel [J]. J Pharmacol Exp Ther, 2001,298:1236-1242.
10. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells [J]. Cancer Res, 2003,63:1515-1519.
11. Hua J, Mutch DG, Herzog TJ. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line [J]. Gynecol Oncol, 2005,98:31-38.
12. Zhan M, Yu D, Lang A, et al. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression [J]. Cancer, 2001,92:1556-1566.
13. Ding Y, He LR, Cao KJ, et al. Apoptosis of human carcinoma of mouth floor KB cells and multidrug resistant KBv200 cells induced by azide methyl anthraquinone derivative [J]. Acta Pharm Sin, 2005,40:22-26.
14. Wang JC, Liu XY, Lu WL, et al. The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes [J]. Acta Pharm Sin, 2005,40:475-480.
15. Zhai BJ, Wu F, Shao ZY, et al. Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/ADM) and biological characteristics evaluation [J]. Chin J Cancer, 2004,23:391-396.